ORM2 and pancreatic serous cystadenoma: The recent reports of the occurrence of aGP2 IgA in patients with large biliary duct disorders including PSC and of aGP2 IgA as marker of severe disease, as well as cholangiocarcinoma ushered in a new era in PSC serology (7, 31).